Clinical Trials Directory

Trials / Completed

CompletedNCT01971099

Effects of Tribulus Terrestris in Women With Hypoactive Sexual Desire Disorder

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Federal University of Minas Gerais · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Not accepted

Summary

Hypoactive Sexual Desire Disorder (HSDD) is the most prevalent female sexual dysfunction in society and is strongly linked to the quality of life of women. The androgen hormones decline over age in the premenopausal period, which occurs around 20 years. Tribulus terrestris is a plant native to India, recommended in the treatment of infertility, low libido and impotence. Its main active ingredient is the protodioscin, which has been attributed to an increase in testosterone levels and improved sexual function. The aim of this study is to evaluate the effects of Tribulus Terrestris in premenopausal women with HSDD.

Conditions

Interventions

TypeNameDescription
DRUGtribulus terrestrispatients will use 750mg/day of tribulus terrestris
OTHERPlacebopatients will take one pill a day (the same shape of the drug)

Timeline

Start date
2013-05-01
Primary completion
2015-07-01
Completion
2015-09-01
First posted
2013-10-29
Last updated
2016-01-14

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT01971099. Inclusion in this directory is not an endorsement.